Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevidipine in neurosurgical patients
NCT00952081Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Jul 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clevidipine in hypertension (HTN), sponsored by NYU Langone Health. Primary endpoint: Proportion of Patients Who Did Not Require Rescue Antihypertensive Medication to Maintain SBP Below 130 mmHg. Started Jul 2009; status: completed.
02
Drugs
clevidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00952081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00952081.